HAV & B19 Testing Services
NHS Blood and Transplant
This tender has closed
The submission deadline for this contract has passed. There may be more active services tenders from NHS Blood and Transplant, and hundreds more across the UK public sector.
Get tenders like this by email
New tenders like this one, in your inbox every morning. Starts with 14 days of Pro, no card needed.
Unsubscribe in one click. See our privacy policy.
Key details
Procurement
- 71900000 Laboratory services
- 48921000 Automation system
- 33141625 Diagnostic kits
- 33696500 Laboratory reagents
- 33124110 Diagnostic systems
- 33140000 Medical consumables
- 33124000 Diagnostics and radiodiagnostic devices and supplies
- 33696200 Blood-testing reagents
- 33127000 Immuno-analysis devices
- 33000000 Medical equipments, pharmaceuticals and personal care products
What happened
NHS Blood and Transplant awarded this contract to Grifols UK Limited on 11 Dec 2023. The contract runs until 18 Oct 2030.
Description
This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a fully integrated high throughput testing solution for the detection of hepatitis A virus (HAV) RNA and Parvovirus B19 DNA in partnership with NHSBT. Additionally, the solution must also be able to test for HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA as contingency during a business continuity need for NHSBTs . The solution must have the relevant UKCA marking to support this ability.
Participation is subject to the Supplier currently participating in the NHSBT KEG process, or confirmation that their testing solution has previously been KEG approved to deliver HAV & B19 Screening Services in partnership with NHSBT. All correspondence to: [email protected]
Awarded supplier
Contact
Identifiers
Explore related tenders
Other tenders from NHS Blood and Transplant
View all →External ID: fts-ocds-h6vhtk-03e147 • Added 6 August 2026